ATE350474T1 - Bpc-1: ein ausgeschiedenes gehirnspezifisches protein das von prostata- und blasen-krebszellen exprimiert und ausgeschieden wird - Google Patents

Bpc-1: ein ausgeschiedenes gehirnspezifisches protein das von prostata- und blasen-krebszellen exprimiert und ausgeschieden wird

Info

Publication number
ATE350474T1
ATE350474T1 AT99942113T AT99942113T ATE350474T1 AT E350474 T1 ATE350474 T1 AT E350474T1 AT 99942113 T AT99942113 T AT 99942113T AT 99942113 T AT99942113 T AT 99942113T AT E350474 T1 ATE350474 T1 AT E350474T1
Authority
AT
Austria
Prior art keywords
bpc
secreted
cancer cells
expressed
bladder cancer
Prior art date
Application number
AT99942113T
Other languages
English (en)
Inventor
Daniel E Afar
Rene S Hubert
Kahan Leong
Arthur B Raitano
Douglas C Saffran
Aya Jakobovits
Original Assignee
Agensys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys Inc filed Critical Agensys Inc
Application granted granted Critical
Publication of ATE350474T1 publication Critical patent/ATE350474T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
AT99942113T 1998-08-10 1999-08-10 Bpc-1: ein ausgeschiedenes gehirnspezifisches protein das von prostata- und blasen-krebszellen exprimiert und ausgeschieden wird ATE350474T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9598298P 1998-08-10 1998-08-10

Publications (1)

Publication Number Publication Date
ATE350474T1 true ATE350474T1 (de) 2007-01-15

Family

ID=22254489

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99942113T ATE350474T1 (de) 1998-08-10 1999-08-10 Bpc-1: ein ausgeschiedenes gehirnspezifisches protein das von prostata- und blasen-krebszellen exprimiert und ausgeschieden wird

Country Status (9)

Country Link
US (4) US6277972B1 (de)
EP (1) EP1104462B1 (de)
JP (2) JP4282906B2 (de)
AT (1) ATE350474T1 (de)
AU (1) AU756452B2 (de)
CA (1) CA2338982C (de)
DE (1) DE69934694T2 (de)
IL (2) IL141061A0 (de)
WO (1) WO2000009691A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276488B2 (en) * 1997-06-04 2007-10-02 Oxford Biomedica (Uk) Limited Vector system
CA2292760A1 (en) * 1997-06-04 1998-12-10 Oxford Biomedica (Uk) Limited Vector
US7635687B2 (en) * 1997-06-04 2009-12-22 Oxford Biomedica (Uk) Limited Vector system
US8096872B2 (en) * 1998-06-22 2012-01-17 Igt Method and apparatus for providing electronic credits at a gaming device without first requiring payment therefor
WO2000009691A2 (en) 1998-08-10 2000-02-24 Urogenesys, Inc. Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
WO2000071711A2 (en) * 1999-05-20 2000-11-30 Fahri Saatcioglu Differentially expressed genes in prostate cancer
US7189565B2 (en) * 2001-03-23 2007-03-13 Fahri Saatcioglu Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
US7611892B2 (en) * 2000-03-24 2009-11-03 President And Fellows Of Harvard College Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2002004508A1 (de) * 2000-07-07 2002-01-17 Boehringer Ingelheim International Gmbh Tumorassoziiertes antigen (b345), gekennzeichnet durch eine aminosäuresequenz wie in seq. id. no. 4
US7390263B1 (en) * 2000-10-19 2008-06-24 Igt Method of implementing cashless play of gaming devices interconnected by a computer network
GB0126378D0 (en) * 2001-11-02 2002-01-02 Oxford Biomedica Ltd Antigen
WO2003068967A2 (en) * 2002-02-18 2003-08-21 Lynkeus Bio Tech Gmbh Novel retina specific human proteins wdr17, net01, protein kinase a203, protein kinase mak a194, protein a105, protein a106 and c12orf3variants
US20040018580A1 (en) * 2002-05-10 2004-01-29 Chai Karl X. Synthetic substrates for prostasin
WO2004067716A2 (en) * 2003-01-24 2004-08-12 Agensys, Inc. Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer
CA2515208A1 (en) * 2003-02-07 2004-08-26 The Regents Of The University Of California Nell peptide expression systems and bone formation activity of nell peptide
WO2005027845A2 (en) * 2003-09-18 2005-03-31 Alexion Pharmaceuticals, Inc. Method of identifying cell surface molecules involved in cancer metastasis
US10155816B2 (en) * 2005-11-28 2018-12-18 Genmab A/S Recombinant monovalent antibodies and methods for production thereof
WO2008013541A2 (en) * 2006-07-25 2008-01-31 Walker Digital, Llc Method and apparatus for conditional payouts in a gaming device
CN101918836B (zh) * 2007-05-08 2014-04-30 皮可贝拉有限责任公司 诊断和治疗前列腺癌和肺癌的方法
JP2009245920A (ja) * 2008-03-11 2009-10-22 Sony Corp 燃料電池、電子機器および燃料電池用緩衝液

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
ATE302789T1 (de) * 1993-02-09 2005-09-15 Univ Johns Hopkins Med Zellkernmatrixproteine
WO1997039139A1 (en) * 1996-04-16 1997-10-23 Smithkline Beecham Corporation A method for detection of prostate specific antigen used in monitoring and diagnosis of prostate cancer
WO2000009691A2 (en) * 1998-08-10 2000-02-24 Urogenesys, Inc. Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
CA2296792A1 (en) 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
US20020164705A1 (en) 2001-01-08 2002-11-07 Rajasekhar Bandaru 39362, a novel human CUB domain-containing protein family member and uses thereof
WO2002090504A2 (en) 2001-05-03 2002-11-14 Curagen Corporation Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
CA2453985A1 (en) 2001-07-17 2003-04-03 Incyte Genomics, Inc. Receptors and membrane-associated proteins

Also Published As

Publication number Publication date
AU756452B2 (en) 2003-01-16
US7785811B2 (en) 2010-08-31
JP4637055B2 (ja) 2011-02-23
JP2002522076A (ja) 2002-07-23
CA2338982C (en) 2011-03-15
DE69934694T2 (de) 2007-10-04
WO2000009691A9 (en) 2000-08-03
WO2000009691A3 (en) 2000-05-11
US8003758B2 (en) 2011-08-23
US20020161212A1 (en) 2002-10-31
US20050148012A1 (en) 2005-07-07
DE69934694D1 (de) 2007-02-15
AU5556199A (en) 2000-03-06
JP4282906B2 (ja) 2009-06-24
JP2006320324A (ja) 2006-11-30
WO2000009691A2 (en) 2000-02-24
US20100168027A1 (en) 2010-07-01
EP1104462B1 (de) 2007-01-03
CA2338982A1 (en) 2000-02-24
IL141061A (en) 2009-12-24
US6277972B1 (en) 2001-08-21
IL141061A0 (en) 2002-02-10
EP1104462A2 (de) 2001-06-06

Similar Documents

Publication Publication Date Title
ATE350474T1 (de) Bpc-1: ein ausgeschiedenes gehirnspezifisches protein das von prostata- und blasen-krebszellen exprimiert und ausgeschieden wird
NZ335531A (en) Composition and methods of producing human cartilage tissue
IL149046A0 (en) 36p6d5: secreted tumor antigen
TW428026B (en) Bifunctional protein, preparation and use
TW200728465A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
SI1615952T1 (sl) Metoda zdravljenja vnetnih bolezni z uporabo specifičnih veznih sredstev humanega angiopoetin
MXPA02000192A (es) Composiciones y metodos para la terapia y diagnostico de cancer de pulmon.
WO2002010382A3 (en) Trp8, trp9 and trp10, markers for cancer
WO2000040614A3 (en) Characterization of the soc/crac calcium channel protein family
ES2102196T3 (es) Periferializacion de celulas pluripotenciales hematopoyeticas.
WO2004110345A8 (en) Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
MXPA03001984A (es) Variantes de factor vii de coagulacion humano.
ATE510552T1 (de) Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors
IT8921243A0 (it) Nuovi geni ibridi funzionali di bacillus thuringiensis ottenuti mediante ricombinazione in vivo.
BR0010702A (pt) Novas quinonas como terapias de doenças
BRPI0416686A (pt) composição para obter benefìcios na pele usando intermediários metabólicos celulares chave.
ATE309382T1 (de) Rekombinante adenovirenvektoren zur gentherapie der menschlichen krebse
WO2002050111A3 (en) Isolated laminin 10
MXPA02011563A (es) Composicionesy metodos para la terapia y diagnostico de cancer de seno.
WO2004003166A3 (en) Antibodies and uses thereof
TR200200278T2 (tr) Kalsilitik bileşimler
CA2067797A1 (en) Production and use of human nm23 protein and antibodies therefor
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
YU63702A (sh) Novo antitelo sa specifičnošću za rak debelog creva

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties